At Simulations Plus, we believe the future of drug development will be shaped by scientists who can explore complex questions with clarity, confidence, and rigor. Modeling, simulation, and AI are no longer optional tools, they are becoming the foundation of model-informed decision-making across the drug lifecycle.
Our University+ program exists to support that future.
We provide students and instructors with access to the same validated scientific engines used by industry and regulators, enabling academic research that reflects how modern drug development is practiced. Through this program, emerging scientists can build the skills, intuition, and judgment needed to translate data into meaningful insight.
By completing this form, you are applying for access to one or more of the following platforms: GastroPlus®, ADMET Predictor®, DILIsym®, and MonolixSuite™, each part of an evolving ecosystem that connects discovery, development, and decision-making.
Approved applicants will receive an academic license for one year. Software is delivered via on-premise installation, ensuring a consistent and reproducible environment aligned with academic workflows.